reference/35330504

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35330504

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1662-5099
pageRange	963083-
publicationName	Frontiers in Molecular Neuroscience
startingPage	963083
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c1c4b2239c1fe2047bc2eb3481c88a0a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_261d1728d006fc5b74b5ff883d9ecd89 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_10356d75444048cadb22c15331f33e08 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6212ac6beb65076cbc6272d42ec9230b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70abf1ffb7b93a873efff855532f08ab
bibliographicCitation	Wu Y, Meng W, Guan M, Zhao X, Zhang C, Fang Q, Zhang Y, Sun Z, Cai M, Huang D, Yang X, Yu Y, Cui Y, He S, Chai R. Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress. Front Mol Neurosci. 2022;15():963083. PMID: 35992197; PMCID: PMC9381809.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b14dd1e6674b8d0b3f0d4eb52cc54b5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_758b2eaa5e66d5c2effa65c73421f1a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee615fbe44bdbdab18149deb9a635503 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfff567860659c649541337966d197b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e18cb099741ca04ea72594c680e10ee1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4788e38c815b6702db6c4ea12b8d6ab4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_487bf7606ab54e2dbae9e169c07901ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31e7ce6c146f90a909040a9d5c812d26 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67d7008741694d1368ef7e01769c0ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6a1fa62d3f229a69c82261e8185f33e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cc3c5dbe42af9aa5f19251466d56bfb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae9d56d09b7682800b8a68812b0db9fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7df8c8a04c5edc39fc746b8df9747cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ef099a11e9de485f27d78918d294cba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d34a5fe435e7ba07ccdada13fa8591c
date	2022-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3389/fnmol.2022.963083 https://pubmed.ncbi.nlm.nih.gov/35992197 https://pubmed.ncbi.nlm.nih.gov/PMC9381809
isPartOf	https://portal.issn.org/resource/ISSN/1662-5099 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34620
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3f5c5ffe69f7233269fad9486f871895 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6a92c22bd1370321572b5db0b74dc7a5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6717 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_67aadc7c7b2194fc04decca410c17b42 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7915 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8305 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f8236315243bf6f111e1cdc1d401f84 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10757

Total number of triples: 48.